510 related articles for article (PubMed ID: 26754641)
21. A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease.
Edwin TH; Henjum K; Nilsson LNG; Watne LO; Persson K; Eldholm RS; Saltvedt I; Halaas NB; Selbæk G; Engedal K; Strand BH; Knapskog AB
Alzheimers Dement (Amst); 2020; 12(1):e12128. PubMed ID: 33313376
[TBL] [Abstract][Full Text] [Related]
22. The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum.
Shi X; Zhong X; Zhou H; Zhou N; Hu Y; Ning Y;
Front Neurol; 2022; 13():961842. PubMed ID: 36408515
[TBL] [Abstract][Full Text] [Related]
23. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.
Rosenthal SL; Bamne MN; Wang X; Berman S; Snitz BE; Klunk WE; Sweet RA; Demirci FY; Lopez OL; Kamboh MI
Neurobiol Aging; 2015 Aug; 36(8):2443.e21-6. PubMed ID: 26058841
[TBL] [Abstract][Full Text] [Related]
24. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.
Ayer AH; Wojta K; Ramos EM; Dokuru D; Chen JA; Karydas AM; Papatriantafyllou JD; Agiomyrgiannakis D; Kamtsadeli V; Tsinia N; Sali D; Gylys KH; Agosta F; Filippi M; Small GW; Bennett DA; Gearing M; Juncos JL; Kramer J; Lee SE; Yokoyama JS; Mendez MF; Chui H; Zarow C; Ringman JM; Kilic U; Babacan-Yildiz G; Levey A; DeCarli CS; Cotman CW; Boxer AL; Miller BL; Coppola G
Alzheimer Dis Assoc Disord; 2019; 33(4):327-330. PubMed ID: 31513029
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants.
Dash R; Choi HJ; Moon IS
Sci Rep; 2020 Feb; 10(1):3663. PubMed ID: 32107424
[TBL] [Abstract][Full Text] [Related]
26. Homozygous TREM2 c.549del; p.(Leu184Serfs*5) variant causing Nasu-Hakola disease in three siblings in a consanguineous Iraqi family: Case report and review of literature.
Gilani N; Bitarafan F; Ozaslan M; Åsheim S; Heidari M; Garshasbi M
Mol Genet Genomic Med; 2024 Jun; 12(6):e2476. PubMed ID: 38888203
[TBL] [Abstract][Full Text] [Related]
27. The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
Engelman CD; Darst BF; Bilgel M; Vasiljevic E; Koscik RL; Jedynak BM; Johnson SC
Neurobiol Aging; 2018 Jun; 66():177.e1-177.e5. PubMed ID: 29395285
[TBL] [Abstract][Full Text] [Related]
28. Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression.
Reichert Plaska C; Heslegrave A; Bruno D; Ramos-Cejudo J; Han Lee S; Osorio R; Imbimbo BP; Zetterberg H; Blennow K; Pomara N
Brain Behav Immun; 2024 May; 120():248-255. PubMed ID: 38795783
[TBL] [Abstract][Full Text] [Related]
29. Decoding sTREM2: its impact on Alzheimer's disease - a comprehensive review of mechanisms and implications.
Lin C; Kong Y; Chen Q; Zeng J; Pan X; Miao J
Front Aging Neurosci; 2024; 16():1420731. PubMed ID: 38912524
[TBL] [Abstract][Full Text] [Related]
30. TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
Kiianitsa K; Lukes ME; Hayes BJ; Brutman J; Valdmanis PN; Bird TD; Raskind WH; Korvatska O
Brain; 2024 Jan; ():. PubMed ID: 38226698
[TBL] [Abstract][Full Text] [Related]
31. Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease.
Satoh JI; Yanaizu M; Tosaki Y; Sakai K; Kino Y
Intractable Rare Dis Res; 2016 Nov; 5(4):269-274. PubMed ID: 27904822
[TBL] [Abstract][Full Text] [Related]
32. Functional insights from biophysical study of TREM2 interactions with apoE and Aβ
Kober DL; Stuchell-Brereton MD; Kluender CE; Dean HB; Strickland MR; Steinberg DF; Nelson SS; Baban B; Holtzman DM; Frieden C; Alexander-Brett J; Roberson ED; Song Y; Brett TJ
Alzheimers Dement; 2020 Oct; ():. PubMed ID: 33090700
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the genetic variance of late-onset Alzheimer's disease.
Ridge PG; Hoyt KB; Boehme K; Mukherjee S; Crane PK; Haines JL; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD; Kauwe JSK;
Neurobiol Aging; 2016 May; 41():200.e13-200.e20. PubMed ID: 27036079
[TBL] [Abstract][Full Text] [Related]
34. The role of TREM2 in Alzheimer's disease: from the perspective of Tau.
Huang W; Huang J; Huang N; Luo Y
Front Cell Dev Biol; 2023; 11():1280257. PubMed ID: 38020891
[TBL] [Abstract][Full Text] [Related]
35. MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.
You SF; Brase L; Filipello F; Iyer AK; Del-Aguila J; He J; D'Oliveira Albanus R; Budde J; Norton J; Gentsch J; Dräger NM; Sattler SM; Kampmann M; Piccio L; Morris JC; Perrin RJ; McDade E; ; Paul SM; Cashikar AG; Benitez BA; Harari O; Karch CM
medRxiv; 2023 Feb; ():. PubMed ID: 36798226
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of Alzheimer's disease genetic variants in microglia.
Yang X; Wen J; Yang H; Jones IR; Zhu X; Liu W; Li B; Clelland CD; Luo W; Wong MY; Ren X; Cui X; Song M; Liu H; Chen C; Eng N; Ravichandran M; Sun Y; Lee D; Van Buren E; Jiang MZ; Chan CSY; Ye CJ; Perera RM; Gan L; Li Y; Shen Y
Nat Genet; 2023 Oct; 55(10):1735-1744. PubMed ID: 37735198
[TBL] [Abstract][Full Text] [Related]
37. Neuraminidase 1 regulates the cellular state of microglia by modulating the sialylation of Trem2.
Fremuth LE; Hu H; van de Vlekkert D; Annunziata I; Weesner JA; Gomero E; d'Azzo A
bioRxiv; 2024 May; ():. PubMed ID: 38826426
[TBL] [Abstract][Full Text] [Related]
38. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.
Brase L; You SF; D'Oliveira Albanus R; Del-Aguila JL; Dai Y; Novotny BC; Soriano-Tarraga C; Dykstra T; Fernandez MV; Budde JP; Bergmann K; Morris JC; Bateman RJ; Perrin RJ; McDade E; Xiong C; Goate AM; Farlow M; ; Sutherland GT; Kipnis J; Karch CM; Benitez BA; Harari O
Nat Commun; 2023 Apr; 14(1):2314. PubMed ID: 37085492
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Tijms BM; Vromen EM; Mjaavatten O; Holstege H; Reus LM; van der Lee S; Wesenhagen KEJ; Lorenzini L; Vermunt L; Venkatraghavan V; Tesi N; Tomassen J; den Braber A; Goossens J; Vanmechelen E; Barkhof F; Pijnenburg YAL; van der Flier WM; Teunissen CE; Berven FS; Visser PJ
Nat Aging; 2024 Jan; 4(1):33-47. PubMed ID: 38195725
[TBL] [Abstract][Full Text] [Related]
40. Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
Qiao W; Chen Y; Zhong J; Madden BJ; Charlesworth CM; Martens YA; Liu CC; Knight J; Ikezu TC; Kurti A; Zhu Y; Meneses A; Rosenberg CL; Kuchenbecker LA; Vanmaele LK; Li F; Chen K; Shue F; Dacquel MV; Fryer J; Pandey A; Zhao N; Bu G
Mol Neurodegener; 2023 Apr; 18(1):28. PubMed ID: 37118783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
